Air oxidation of 1,3,6,8-tetrahydroxy-2,7-naphthyridine afforded 2,5,8,11-tetraaza-5,11-dihydro-4,10-dihydroxyperylene-1,3,6,7,9,12-hexaone. X-ray crystallography of the product revealed that it exists in the meso form in the solid state. The mechanism of product formation most likely involves oxidative phenolic coupling and oxidation. The product proved to be a competitive inhibitor of Schizosaccharomyces pombe lumazine synthase with a K i of 66 ( 13 µM in Tris buffer and 22 ( 4 µM in phosphate buffer. This is significantly more potent than the reactant (K i 350 ( 76 µM, competitive inhibition), which had previously been identified as a lumazine synthase inhibitor by high-throughput screening. Ab initio calculations indicate that the meso form is slightly less stable than the enantiomeric form, and that the two forms interconvert rapidly at room temperature.
Introduction
Riboflavin (4, vitamin B 2 ) is essential for life. It plays a crucial role in many biological processes, including photosynthesis and mitochondrial electron transport. Whereas animals obtain riboflavin from dietary sources, certain microorganisms such as Gram-negative pathogenic bacteria and yeasts lack an efficient riboflavin uptake system and are therefore absolutely dependent on endogenous riboflavin biosynthesis. 1-4 Riboflavin biosynthesis is therefore an attractive target for the design and synthesis of new antibiotics, which are urgently needed because pathogens are becoming drug resistant at an alarming rate.
Lumazine synthase catalyzes the penultimate step in the biosynthesis of riboflavin (Scheme 1). Although the precise details remain to be established, the lumazine synthase-catalyzed reaction most likely proceeds along the mechanistic pathway involving Schiff base formation, phosphate elimination, tautomerization, ring closure, and dehydration. 5 High-throughput screening (HTS) employs large libraries of compounds to identify those of biological interest. We recently developed a high-throughput screen utilizing the fluorescence of riboflavin for identification of lumazine synthase inhibitors. 6 The method utilizes the displacement of riboflavin, which is fluorescent, from a nonfluorescent complex of Schizosaccharomyces pombe lumazine synthase with riboflavin. Highthroughput screening of a commercial library of about 100 000 compounds using this assay resulted in the identification of a 1,3,6,8-tetrahydroxynaphthyridine (7) 7 as a potential lumazine synthase inhibitor. The present communication describes the characterization and confirmation of 7 as a lumazine synthase inhibitor as well as its conversion to a more active compound.
Results and Discussion
In order to confirm the structure of naphthyridine 7, samples of it were obtained both commercially (Aldrich Chemical Co.) and also by synthesis from malononitrile (5) and diethyl acetonedicarboxylate (6) in refluxing ethanol containing a catalytic amount of diethylamine (Scheme 2). Removal of the solvent yielded a residue that was treated with sulfuric acid and then diluted with water to provide the desired product 7 (mp >350°C, EIHRMS m/z calcd for C 8 H 6 N 2 O 4 195.0406, found 195.0403). The 1 H NMR and 13 C NMR spectra of 7 indicate that it exists in solution as a complex mixture of amide and lactim tautomers. Enzyme kinetics revealed that the synthetic naphthyridine 7 prepared in our laboratories is a relatively weak S. pombe lumazine synthase inhibitor with a K i of 350 ( 76 µM. This was less potent than the commercial sample of 7, and more detailed studies revealed that the potency of the synthetic sample seemed to increase on storage in solution. In view of these results, an effort was made to characterize the synthetic material in more detail and to investigate the possible reasons for the observed increase in potency on storage of the synthetic material in solution.
During the characterization of naphthyridine 7, a sample of it was dissolved in DMSO and the solution was left standing open to air for a week. This resulted in a change in color of the solution from yellow to dark red. After a month, dark red needles crystallized from the solution. X-ray crystallography revealed that the red needles were 2,5,8,11-tetraaza-5,11-dihydro-4,10-dihydroxyperylene-1,3,6,7,9,12-hexaone (8, Scheme 3).
Because of steric hindrance between the two carboxyl oxygens at C-6 and C-7, as well as at C-1 and C-12, the perylenehexaone system 8 can theoretically exist in a number of stereoisomeric forms. If one only considers the three stereoisomers in which these pairs of carbonyl oxygens are on opposite sides of the ring system, the tetraazaperylenehexaone 8 can exist either as a meso compound or as a pair of two enantiomers (Figure 1 ). The crystal structure space group was determined to be P1 (No. 2), which is only consistent with the tetraazaperylenehexaone 8 existing in the solid state as the meso compound. The crystal structure of 8, which contains two solvent-derived molecules of DMSO, is displayed in Figure 2 . The orientations of the carbonyl oxygens at C-6, C-7, C-1, and C-12 are clearly visible from the crystal structure, which also proves that the tetraazaperylenehexaone 8 crystallized in the meso form and not as the racemate.
The mechanism of the reaction leading to the tetraazaperylenehexaone 8 most likely involves oxidative phenolic coupling of the radical species 9 and 10, followed by a four-electron oxidation (Scheme 4). Oxidative C-C coupling reactions of phenols are well-known processes that are usually catalyzed by The transition state depicted is the one between enantiomer (a) and the meso compound. metals (typically copper), [8] [9] [10] dicopper-dioxygen complexes, 11 enzymes, 10,12,13 or various reactive oxygen species. 14 In the present case the oxidant is unidentified. The reaction mixture was left open to the atmosphere for a period of a month before the product began to crystallize from solution.
Surprisingly, the tetraazaperylenehexaone system 8 proved to be a more potent inhibitor of S. pombe lumazine synthase than the original HTS hit compound 7. As mentioned above, the K i of the original compound 7 was of 350 ( 76 µM, while that of the oxidative phenolic coupling product 8 was 66 ( 13 µM in Tris buffer, pH 7.0.
Molecular modeling was performed in order to investigate the binding of the meso isomer of compound 8 to the enzyme.
Both inorganic phosphate and riboflavin were removed from the structure of the S. pombe lumazine synthase complex with riboflavin (PDB code 1KYV), 15 and the oxidation product 8 was then docked into the apoenzyme structure using Gold software (BST, version 3.0, 2005). The reason that the inorganic phosphate was removed from the structure before docking 8 was that the inhibition assay was initially carried out in phosphate-free buffer. Energy minimization was then performed using Sybyl 7.1. The resulting structure is displayed in Figure 3 . According to the theoretical model, the binding of the red dimer 8 in the active site of S. pombe lumazine synthase is similar to that of riboflavin (4), as well as to that of substrate and product analogues. 15 As with riboflavin (4) and the substrate and product analogues 12 16,17 and 13, 17-19 the binding is stabilized by stacking interactions involving Tyr27 and His94 ( Figure 3) . 15 In addition, the binding of the red dimer 8 to the enzyme could be mediated by hydrogen bonding interactions involving the backbone NH of Ile88, the backbone carbonyl of Val86, and the backbone NH of Ser62 (Figure 3 ). Similar protein contacts are evident at the pyrimidinedione rings in the crystal structures of riboflavin (4) and the substrate and product analogues 12 and 13. However, additional contacts are possible with the red dimer 8 that are not present with the other ligands. These include hydrogen-bonding contacts with the side chain guanidine moiety of Arg133, the side chain hydroxyl of Thr92, and water-mediated contacts with Trp146 and Asp145. Taken together, the molecular modeling results indicate that the binding of the red dimer 8 in the active site of S. pombe lumazine synthase is certainly plausible; it is also reasonable that it could be stabilized by some of the same forces that stabilize the binding of riboflavin (4), the substrate analogue 12, and the product analogue 13. This point is emphasized in Figure 4 , which shows how the red dimer 8 is calculated to bind compared to the observed position of riboflavin (4) in the crystal structures. It is clear from Figure 4 that there is considerable overlap in the space occupied by riboflavin and the space calculated to be occupied by the red dimer 8.
The inhibition constants specified above were determined in Tris buffer at pH 7.0. Since in some cases the presence of inorganic phosphate has previously been demonstrated to affect the binding constants of lumazine synthase inhibitors, the .0, 100 mM NaCl, 5 mM EDTA, 5 mM DTT, reaction mixture volume 1 mL. 5-Amino-6-ribitylaminopyrimidinedione concentration range, 2 -20 µM; 3,4-dihydroxy-2-butanone-4-phosphate, 100 µM; compound concentrations 0, 20, 40, 80 µM. b Assay buffer: 100 mM K/Na-phosphate, pH 7.0, 5 mM EDTA, 5 mM DTT, reaction mixture volume 1 mL. 5-Amino-6-ribitylaminopyrimidinedione concentration range, 1.5 -15 µM; 3,4-dihydroxy-2-butanone-4-phosphate, 100 µM; compound concentrations 0, 25, 50, 75 µM.
binding of the red dimer 8 was also studied in phosphate buffer at pH 7.0. The results of the inhibition experiments vs S. pombe lumazine synthase are listed in Table 1 . The results reveal that the red dimer 8 is a more potent inhibitor of S. pombe lumazine synthase in the presence of phosphate, producing a K i of 22 µM in phosphate buffer as opposed to 66 µM in Tris buffer. Competitive inhibition occurred in each case as indicated by analysis of the Lineweaver-Burke enzyme kinetics plots using the DynaFit program 20 ( Figure 5) .
The crystal structure of S. pombe lumazine synthase complex with riboflavin (PDB code 1KYV) 15 contains an inorganic phosphate molecule that occupies the binding site of the organic phosphate moiety present in the substrate 2 (Scheme 2). The increase in inhibitory potency of the red dimer 8 in phosphate buffer is significant because inorganic phosphate could possibly be present in the active site of lumazine synthase under cellular conditions, although if present it would obviously have to be displaced by the phosphate of the substrate 2 during catalysis. In order to gain insight into the increased potency of 8 in the presence of phosphate, it was docked in the active site of the enzyme with phosphate bound using the Gold docking program, and the model resulting after energy minimization using the 4. Hypothetical structure of the meso conformer of the red dimer 8 bound in the active site of S. pombe lumazine synthase superimposed on the crystal structure of riboflavin (4) bound in the active site of S. pombe lumazine synthase. Yellow: dimer 8, magenta: riboflavin (4); red, theoretical locations of amino acid residues in the enzyme/8 complex; green: amino acid residues in the crystal structure of the enzyme/4 complex. The diagram is programmed for wall-eyed (relaxed) viewing.
MMFF94s force field within Sybyl 7.1 is displayed in Figure 6 . The model indicates that the increased potency in the presence of phosphate could be due to hydrogen bonding of one of the imide moieties present in the red dimer 8 to the inorganic phosphate molecule in the active site of the enzyme.
In addition to the meso conformer of the red dimer 8, the two enantiomeric conformers (a and b) (Figure 1) were docked in the active site of the enzyme in the absence of phosphate (Figure 7 ) and the energies of the complexes minimized. Interestingly, the molecular mechanics energy calculations (Table 2) argue that the complex derived from the meso conformer is more stable than those derived from either of the enantiomers, and that the binding energy of the meso form to the enzyme is more favorable than either enantiomer. Furthermore, while the planes of all three ligand structures overlapped closely, and the orientations of the meso form and enantiomer a were very close, enantiomer b was rotated approximately 90°r elative to the other two (Figure 7) . The calculated protein structures of all three complexes overlapped very closely, even though the protein structure was allowed to move during energy minimization. The three structures used to construct Figure 7 are displayed individually in the Supporting Information, together with the hydrogen-bonding contacts between the ligands and the protein structure.
Ab initio quantum mechanics calculations were performed with Gaussian 03 in order to estimate the relative energies of the meso and enantiomeric forms, as well as the transition state between the two forms. Among the ab initio techniques, density functional theory has been well established as a powerful tool that, in contrast to HF theory, includes electron correlation. However, there are reports that DFT may in some cases underestimate transition state barriers. 21 Therefore, the results of both DFT and HF calculations were obtained and both are listed in Table 3 .
Starting from the crystal structure of the meso isomer of compound 8, the structures of both enantiomers were built and fully optimized using the MOPAC AM1 method (with molecular mechanics correction of the CONH bonds, implemented within Sybyl 7.1). The three forms were then optimized using the restricted Hartree-Fock equation and the 3-21G basis set. The QST3 method was used to locate the transition state for the conversion of the meso form to one of the enantiomers using RHF/3-21G within Gaussian 03 (Revision C.02). 22 The meso form and the two enantiomers were further optimized using RHF/6-31G(d) and finally refined using density functional theory at B3LYP/6-31G(d). The results of these calculations are summarized in Table 3 . The meso form and one of the enantiomers obtained from RHF/6-31G(d) optimization, and the transition state obtained from the RHF/3-21G QST3 calculations, were used in a QST3 calculation to locate the transition state at RHF/6-31G(d). Similarly, the meso form and one of the enantiomers obtained from B3LYP/6-31G(d) optimization, and the transition state obtained from the RHF/6-31G(d) QST3 calculations were used in a QST3 calculation to locate the transition state at B3LYP/6-31G(d), which represents the final transition state structure used in this study. The optimized structures of the meso form, one of the two enantiomers, and the calculated transition state are displayed in Figure 8 . Frequency check calculation on the transition state structure obtained from DFT calculations yielded only one negative (imaginary) frequency (-105.3 cm -1 ), indicating a valid transition state. The vibrational mode of the imaginary frequency displayed in Figure 9 corresponds precisely to the transition state for conversion of the meso form to one of the enantiomers. The transition state structure has two of the carbonyls on one side in the same plane, and on the other side one carbonyl is "up" and one is "down".
At all of the levels of theory, the activation energy differences are within 2.0 kcal/mol and in good agreement with each other (Table 3 ). The differences in the calculated values could reflect differences in the optimized geometries at various levels as well as differences in the levels of theory. The results of the DFT quantum mechanics calculations indicate that the meso form is 1.5 kcal/mol higher in energy than the enantiomeric form. The activation energy in going from the meso form to the transition state is 4.9 kcal/mol, and the activation energy in going from one of the enantiomers to the transition state is 6.4 kcal/mol (Figure 10 ). On the basis of these theoretical calculations, the meso and enantiomeric forms interconvert rapidly at room temperature. It can also be expected that the crystalline meso form is rapidly converted to the more stable racemate after dissolution. However, the enzyme-bound form is not certain, and the possibility exists that the meso and enantiomeric forms could interconvert while enzyme bound, or that the equilibrium a All the energies were calculated using the MMFF94s force field and MMFF94 charges implemented in Sybyl 7.1 and are expressed in kcal/ mol. E enzyme indicates the energy of the minimized apoenzyme; Ecomplex indicates the energies of the final minimized complexes after ligand binding; Eligand indicates the energies of the minimized ligand structures after extraction from the corresponding complex; Ebinding ) Ecomplex -EligandEenzyme; Gold Fitness is the Gold fitness score.
could be shifted in the bound form to favor either the meso form or one of the enantiomeric forms. Although these calculations were performed in vacuo, the results should provide a valid estimate of the relative energies in aqueous solution because of the very small conformational change of the carbonyls involved in the interconversion of the three forms (meso, transition state, and enantiomer). It is therefore assumed that the solvation energies are similar for all three forms.
Compound 8 represents a new structural prototype for potential lumazine synthase inhibitors. This is a welcome advancement because although the previously synthesized substrate, intermediate, and product analogue inhibitors of lumazine synthase have proven to be valuable structural and mechanistic probes, their potential antibiotic activity is limited by the presence of a very hydrophilic ribityl side chain. 15, [23] [24] [25] [26] [27] [28] [29] [30] [31] It is possible that the perylenehexaone system 8 may provide a Lumazine Synthase Inhibitor
